FreshRecalls

Blaine Labs recalls

8 recent recalls on record for Blaine Labs in CPSC, NHTSA, and FDA data as of July 24, 2026 at 1:09 AM UTC.

Models with recalls

Fungal Fusion ERADICATION Solution (1)Revitaderm Wound Care (1)Revitaderm Wound Care Gel (1)TERPENICOL Antifungal Cream (Undecylenic Acid 13%) (1)TERPENICOL Antifungal Solution (1)TRIFLUENT PHARMA TRIDERGEL Wound Care Gel (1)TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%) (1)vite20 Antifungal Cream (1)

All Blaine Labs recalls

FDA Class II · Drug · July 8, 2026

Revitaderm Wound Care recall — Blaine Labs Inc

CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated

Official ID D-0699-2026 · Official record ↗

FDA Class II · Drug · July 8, 2026

Fungal Fusion ERADICATION Solution recall — Blaine Labs Inc

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Official ID D-0698-2026 · Official record ↗

FDA Class II · Drug · July 8, 2026

TERPENICOL Antifungal Solution recall — Blaine Labs Inc

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Official ID D-0697-2026 · Official record ↗

FDA Class II · Drug · July 8, 2026

vite20 Antifungal Cream recall — Blaine Labs Inc

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Official ID D-0696-2026 · Official record ↗

FDA Class II · Drug · July 8, 2026

TERPENICOL Antifungal Cream (Undecylenic Acid 13%) recall — Blaine Labs Inc

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Official ID D-0695-2026 · Official record ↗

FDA Class II · Drug · July 8, 2026

TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%) recall — Blaine Labs Inc

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Official ID D-0694-2026 · Official record ↗

FDA Class II · Drug · July 8, 2026

TRIFLUENT PHARMA TRIDERGEL Wound Care Gel recall — Blaine Labs Inc

CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated

Official ID D-0693-2026 · Official record ↗

FDA Class I · Drug · July 8, 2026

Revitaderm Wound Care Gel recall — Blaine Labs Inc

Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp

Official ID D-0692-2026 · Official record ↗

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from official public-domain government data. Last checked July 24, 2026 at 1:09 AM UTC.